This proposal is designed to establish a reliable animal model of cocaine dependence for the evaluation of the therapeutic efficacy of potential treatment drugs. The animal model will permit assessment of treatment drug effects on separate aspects of cocaine dependence, including the rewarding value of cocaine, craving, and propensity to relapse. Initially, behavioral parameters of responding for cocaine under different reinforcement contingencies will be established using progressive ratio, concurrent, and multiple schedules . Repeated extinction and spontaneous recovery tests in the presence or absence of environmental cues associated with cocaine availability will provide information about the persistence of cocaine-seeking behavior. The characteristic patterns of responding observed in these behavioral tests will serve as measures of (1) reward magnitude, operationally defined as the """"""""breaking point"""""""" for responding for cocaine on a progressive ratio schedule, (2) degree of preference for cocaine in a drugs vs. food choice situation, (3) craving, operationally defined as the magnitude and duration of extinction responding on a non-reinforced multiple schedule component, and (4) propensity to relapse, operationally defined as the facilitation of spontaneous recovery after introduction of a conditioned stimulus. The behavioral parameters serve as reference points against which the effects of potential treatment drugs will be evaluated. Initial compounds to be tested include agents that act on monoamine and opioid neurotransmission. As other agents become available, subsequent compounds will include neuropeptide analogues and drugs that act on non-monoaminergic systems. These studies have important clinical implications with regard to new drugs that may be effective in treating or preventing cocaine abuse and dependence, and may aid in determining which of the various neuropharmacological actions of cocaine are involved in different components of cocaine dependence.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA007348-01
Application #
3214011
Study Section
Drug Abuse Clinical and Behavioral Research Review Committee (DACB)
Project Start
1991-08-01
Project End
1993-07-30
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Martin-Fardon, Rémi; Cauvi, Gabrielle; Kerr, Tony M et al. (2018) Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food. Addict Biol 23:6-15
Martin-Fardon, Rémi; Weiss, Friedbert (2017) Perseveration of craving: effects of stimuli conditioned to drugs of abuse versus conventional reinforcers differing in demand. Addict Biol 22:923-932
Matzeu, Alessandra; Cauvi, Gabrielle; Kerr, Tony M et al. (2017) The paraventricular nucleus of the thalamus is differentially recruited by stimuli conditioned to the availability of cocaine versus palatable food. Addict Biol 22:70-77
Matzeu, Alessandra; Kerr, Tony M; Weiss, Friedbert et al. (2016) Orexin-A/Hypocretin-1 Mediates Cocaine-Seeking Behavior in the Posterior Paraventricular Nucleus of the Thalamus via Orexin/Hypocretin Receptor-2. J Pharmacol Exp Ther 359:273-279
Matzeu, A; Weiss, F; Martin-Fardon, R (2015) Transient inactivation of the posterior paraventricular nucleus of the thalamus blocks cocaine-seeking behavior. Neurosci Lett 608:34-9
Martin-Fardon, Rémi; Weiss, Friedbert (2014) Blockade of hypocretin receptor-1 preferentially prevents cocaine seeking: comparison with natural reward seeking. Neuroreport 25:485-8
Martin-Fardon, Rémi; Weiss, Friedbert (2012) (-)-2-oxa-4-aminobicylco[3.1.0]hexane-4,6-dicarboxylic acid (LY379268) and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine (MTEP) similarly attenuate stress-induced reinstatement of cocaine seeking. Addict Biol 17:557-64
Hao, Yue; Martin-Fardon, Rémi; Weiss, Friedbert (2010) Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Biol Psychiatry 68:240-8
Martin-Fardon, Rémi; Zorrilla, Eric P; Ciccocioppo, Roberto et al. (2010) Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Res 1314:145-61
Martin-Fardon, R; Baptista, M A S; Dayas, C V et al. (2009) Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer. J Pharmacol Exp Ther 329:1084-90

Showing the most recent 10 out of 39 publications